baber/WOPTO huggingface dataset:
Patent YU-101592-A (YU)
Title: Motor sus sa dva kolenasta vratila i promenljivim stepenom kompresije
Inventor: PESIC R
Filed: 1992-11-25
Abstract: MOTOR SUS SA DVA KOLENASTA VRATILA I PROMENLJIVIM STEPENOM KOMPRESIJE, prema pronalasku, je četvorotaktni klipni motor čiji je motorski mehanizam sastavljen od tri klipnjače: glavne (1), pomoćne (2) i kontrolne (3) i od dva kolenasta vratila: glavnog (5) i pomoćog (6). Glavno kolenasto vratilo (5) je spojeno sa pomoćnim (6) preko lanca (9) i lančanika (7, 8) ili zupčanika. Relativnim faznim pomeranjem pomoćnog (6) u odnosu na glavno kolenasto vratilo (5) menja se dužina fiktivne klipnjače, rastojanje od ose letećeg rukavca do ose osovinice klipa, a time se pomera i SMT što povećava ili smanjuje kompresionu zapreminu odnosno stepen kompresije. Ukoliko je pomoćo kolenasto vratilo (6) povezao sa glavnim kolenastim vratilom (5) prenosnim odnosom 1:2 kod četvorotaktnih motora sa ovim mehanizmom se ostvaruje i produženi hod širenja. Postavljanjem kompresora (K) i gasne turbine (T) čvrstim vezama za vratila dobijamo motor sa nadpunjenjem, koji snagu gasne turbine vraća na kolenasto vratilo kao mehanički rad. Tako se još više podiže ekonomičnost kompleksnog sprega motor-kompresor-turbina.
Patent YU-151689-A (YU)
Title: Process for coloring and printing cellulose fibrouos materials with colors in a bath
IPC: D06P1/22
Filed: 1989-07-28
Abstract: Process for dyeing and printing cellulosic fiber materials with vat dyes in the presence of enediols as reducing agents and alkali, using in addition small amount of organic water-miscible solvents, for example low molecular weight alcohols, when reducing the vat dyes. The vatting of the vat dyes proceeds uniformly and completely within a relatively short time, and the resulting vat dyes are reproducible and notable for high levelness and fastness properties.
Patent YU-193685-A (YU)
Title: Process for preparing new flat-shaped diagnostical product
Inventor: FRIESEN H J
IPC: G01N33/558
Filed: 1985-12-12
Abstract: A solid diagnostic device for the quantitative determination of substances of biological affinity in biological fluids is described. A process is also described in which the biological fluid is brought into contact with a specific functional sector of the device, the fluid migrates through several functional sectors situated beside one another and containing suitable reagent components, and one or more substances of biological affinity are detected in such functional sectors which contain, for each substance to be detected, at least one combination partner of biological affinity, attached to a solid phase.
Patent RS-91204-A (RS)
Title: Lyophilized and liquid preparation comprising a polysaccharide derivative of camptothecin
Inventor: ITO TAKAHIRO
IPC: A61K47/48
Filed: 2003-04-15
Abstract: The present invention relates to a stable liquid preparation comprising a camptothecin derivative which is prepared by binding a compound of the formula [I]:wherein R1 is a substituted or unsubstituted lower alkyl group, X1 is a group of the formula: -NHR2 (R2 is a hydrogen atom or a lower alkyl group) or a hydroxy group and Alk is a straight or branched chain alkylene group optionally interrupted by an oxygen atom, and a polysaccharide having carboxyl groups via an amino acid or a peptide, or a pharmaceutically acceptable salt thereof, which is adjusted to pH 5-8, or a stable pharmaceutical composition produced by lyophilizing said liquid preparation.
Patent AP-41-A (AP)
Title: Electrically operated water heating device
Inventor: HOLLAND JOHN DAVID
IPC: F24H1/10
Filed: 1985-02-19
Granted: 1989-05-04
Abstract: In a preferred form, an electrically operated water heating unit (10) integral with a shower rose (18) and is primarily characterized by the successful use of a "bare" element (22) for ''-' heating the water and by the novel switching arrangement, comprising a first set of contact points (28) mounted through a flexible diaphragm (32) the diaphragm forming the roof of the heating chamber (20), and a second set of contacts (36) aligned so as to engage the first contacts (28) when same are moved upwards by water pressure exerting on the diaphragm (32) during use.
Patent AU-1024092-A (AU)
Title: Recording medium and ink-jet recording method employing the same
Inventor: KURABAYASHI YUTAKA
IPC: B41M5/52
Filed: 1992-01-14
Abstract: A recording medium contains, within an ink absorbent substrate per se or in an ink receiving coat layer formed on a substrate, basic magnesium carbonate together with a cationic surfactant and/or a nonionic surfactant. The recording medium is suitably used for color ink jet recording of the both-ways serial printing type and eliminates substantially the tone difference between forward and backward printings and the discoloration during indoor storage. <IMAGE>
Patent AU-1090899-A (AU)
Title: Formulations and methods for reducing toxicity of antineoplastic agents
Inventor: HAUSHEER FREDERICK H
IPC: A61K33/243
Filed: 1998-10-16
Abstract: This invention provides for pharmaceutical formulations of compounds which are useful as protective agents when administered to patients also receiving antineoplastic drugs. The invention also includes methods of reducing the toxicity of various antineoplastic agents by administering an effective amount of the protective agent to a patient receiving one or more antineoplastic agents. The compounds useful as protective agents have either a sulfhydryl moiety or are reducible disulfides.
Patent AU-1590583-A (AU)
Title: Modular self-routing pcm switching exchange
Inventor: BELFORTE PIERO
IPC: H04Q11/04
Filed: 1983-06-17
Abstract: The PCM switching network is based on the use of switching units (UC1a ... UC8c) each equipped with a local controller using a microprocessor (CTR1a ... CTR8c), ancillary circuits for diagnosis (CDTE1 ... CDTU5), ancillary circuits for exchanging messages relating to network control between the local controllers (CRT1a ... CTR8c) and between local controllers and the distributed telephone control units (CTFa ... CTFc), and ancillary circuits (RTBE1 ... RTBU5) providing virtual channels (on the speech channels themselves) for transmission of said messages in a direction opposite to that of speech. 
<??>Said switching units (UC1a ... UCBc) make it possible to provide self-routing modular PCM switching network structures for distributed-control telephone exchanges.
Patent AU-1611492-A (AU)
Title: Aerosol inhalation device
IPC: A61M15/00
Filed: 1992-05-07
Abstract: An aerosol inhalation device (1) comprises an aerosol holding chamber (15) having attached to one end thereof a flexible cap (16). Flexible cap (16) is adapted to fit over the distal end of a cylindrical shell (17) and comprises an aperture (18) through which a standard inhaler mouthpiece may be sealingly inserted so as to dispense airborne medication into chamber (15). A diaphragm valve mechanism (10) comprises a diaphragm valve support structure (12) having passages (19) extending therethrough. Projecting normal to grid (33) are a number of locating pins (21) which are adapted to extend through holes (30) in diaphragm valve (11). Diaphragm valve (11) formed of flexible material is provided with a pair of cross slits (29) each corresponding with the grid bridge element (39). The central portion (32) of diaphragm valve (11) is located within a major flow passage (19) whereas the outer peripheral edge portion (31) of diaphragm valve (11) is located within exit passage (27). The device (1) further comprises a mouthpiece (22) and optionally a mask (13) to fit over the nose and mouth of a user. Upon breathing inwardly, central portion (32) of diaphragm valve (11) will open whilst at the same time outer edge portion (31) of diaphragm valve (11) will close. Accordingly, aerosol suspended within chamber (15) will pass through the diaphragm valve (11) to be breathed in by the user. Upon the user exhaling, central portion (32) will close and be retained in a closed position against grid (33). At the same time, peripheral outer edge portion (31) of diaphragm valve (11) will open so as to allow the user's exhaled breath to escape via passage (27) and exit ports (37).   <IMAGE>
Patent AU-1657299-A (AU)
Title: Decorative molding assembly for a vehicle door frame
Inventor: ELLIS PETER J
IPC: B60J10/79
Filed: 1998-12-23
Abstract: A decorative molding assembly for a vehicle door frame having a window opening for a transitional window pane moveable between open and closed positions. The molding assembly includes a window door seal mounted to the door frame and having a channel for selective sealing engagement with the window pane. A molding strip has an arm mating with the window door seal and faces outward to provide an appealing appearance. A retaining member engages the arm of the molding strip and the window door seal to secure the molding strip and the window door seal within the window opening of the door frame such that the window pane is securely sealed within the window opening when the window pane is in the closed position.
Patent AU-1662695-A (AU)
Title: Device for releasing a product from a continuously circulating belt
Inventor: KLEINHANS MATTHIAS
IPC: B65G45/12
Filed: 1995-01-28
Abstract: PCT No. PCT/EP95/00302 Sec. 371 Date Nov. 29, 1995 Sec. 102(e) Date Nov. 29, 1995 PCT Filed Jan. 28, 1995 PCT Pub. No. WO95/22498 PCT Pub. Date Aug. 24, 1995An endlessly driven belt extends around a drum and carries a product. Removal of the product from the belt is effected by a doctor blade which bears against a portion of the belt traversing the drum. The doctor blade is fixedly connected to the drum for movement therewith to remain parallel to a surface of the belt. The doctor blade is attached to shafts that are mounted in respective bearing assemblies that permit movement of the shafts along their mutually aligned axes. The doctor blade can be positioned between upstanding ribs formed on the belt whereby the ribs can displace the doctor blade in response to pivoting of the drum in order to keep the doctor blade parallel to the axis of the drum.
Patent AU-1717395-A (AU)
Title: Surgical apparatus
Inventor: BONADIO FRANK
IPC: A61B46/23
Filed: 1995-02-20
Abstract: An access port for use in surgery comprises an elongate sleeve (2) of flexible material having an entry opening (7) located at a proximal end (3) of the sleeve (2) and an exit opening located at a distal end (4) of said sleeve. An inflatable chamber (46) surrounds the sleeve (2) and extends substantially coaxially therewith from the proximal end (3) of the sleeve for a distance along the length of said sleeve. The inflatable chamber (46) when inflated operates to collapse the sleeve (2) to close the entry opening (7). The sleeve (2) is attached to and surrounded by the inflatable chamber (46) with the sleeve (2) extending through the inflatable chamber (46) and outwardly therefrom to provide a projecting flexible sleeve portion (41) extending outwardly from the inflatable chamber (46) to the exit opening at the distal end of said sleeve. The projecting sleeve portion (41) can be inserted through an incision and into a patient's body cavity to provide a flexible sleeve portion adjacent to the exit opening within the body cavity free of a surrounding inflatable chamber. <IMAGE>
Patent AU-1879599-A (AU)
Title: A method for packet authentication in the presence of network address translations and protocol conversions
Inventor: YLONEN TATU
IPC: G09C1/00
Filed: 1998-12-30
Abstract: For achieving packet authentication according to an applicable security policy between a sending node (903) and a receiving node (902) in a network, the following steps are taken:the transformations occurring to a packet en route between the sending node and the receiving node are discovered dynamically (1003, 1004),the discovered transformations are checked (1004) to be acceptable based on the applicable security policy, andthe dynamically discovered, acceptable transformations are compensated for (1004, 1006) before authenticating packets transmitted from the sending node to the receiving node.
Patent AU-2088092-A (AU)
Title: Pharmaceutical spheroid formulation
IPC: A61K9/52
Filed: 1992-08-06
Abstract: A controlled release composition comprising spheroid cores consisting of diltiazem or a pharmaceutically acceptable salt thereof and optionally a spheronising agent, said cores being coated with a controlled release layer. The spheronising agent when present is preferably microcrystalline cellulose. Ethylcellulose is a preferred controlled release coating. The controlled release coating preferably contains a plasticiser, a surfactant and a tack-modifier.
Patent AU-2098900-A (AU)
Title: Device for conveying flat objects between processing equipment items
Inventor: AGIER FRANCOIS
IPC: B65H5/06
Filed: 1999-12-20
Abstract: Device for conveying flat objects (1), held vertically, at high speed between processing equipment items, and in particular for conveying mail envelopes. This device comprises: a stationary baseplate (3) extending from one equipment item to the other, a motorized reference belt (4) stretched over a set of vertical pulleys (7) and extending above the baseplate along the conveying path between equipment items; a motorized press belt (5) mounted in such a way that it can be pressed against the reference belt along the conveying path; a series of defonnable wheels (6) along the conveying path between equipment items, which can come to bear against the press belt in the zone where the latter presses against the reference belt, so as to grip the conveyed envelopes appropriately in spite of the differences in thickness between envelopes.
Patent AU-2325384-A (AU)
Title: Continuous assembly of mailers
Inventor: SIMMONS RANDY D
IPC: B42D5/02
Filed: 1984-01-12
Abstract: A continuous business form assembly including combined mailers and return envelopes is compatible with automatic, non-adjustable slitters.
Patent AU-2332495-A (AU)
Title: Phosphinic acid derivatives, their preparation and their use
Inventor: PEYMANN ANUSCHIRWAN
IPC: C07F9/6584
Filed: 1995-06-28
Abstract: Cyclic phosphinic acid derivs. of formula (I) are new: A = gp. of formulae (a) or (b); n = 0 or 1; Y, R<1> = O or S; R<2> = H, alkyl, alkenyl, etc.; R<3>, R<3>* = H, NH2, alkyl, etc.; or R<3>+R<3>* = 3-6 membered ring opt. contg. 1-3 heteroatoms, e.g. O or N; G, F = H, F, Cl, Br, OH or R<4>; but F = H when G = OH; R<4> = H, 1-20C acyl, or OH pro-drug gp.; B = e.g. -C(L)-; L = e.g. O; D, D* = H, 1-20C Alk<1>, R<6> or R<6>-(1-6C Alk<1>); Alk<1> = satd., mono- or multiply-unsatd. or cyclic alkyl, etc.; R<6> = satd., unsatd. or partly unsatd. 3-35C isocyclic or heterocyclic ring system contg. 3-9 membered rings, etc.; E, E* = H, satd. or unsatd. 1-7C alkyl opt. mono-, di- or tri-substd. by F, Cl, Br or 1-3C alkoxy, etc..
Patent AU-2375884-A (AU)
Title: Organopolysiloxane composition
Inventor: LETOFFE MICHEL
IPC: C08K3/32
Filed: 1984-01-25
Abstract: Organopolysiloxane compositions which rapidly harden to the elastomeric state, even at ambient temperatures, are comprised of (i) a polyhydroxylated polysiloxane, (ii) a polyacyloxysilane cross-linking agent therefor, and (iii) a hardening accelerator comprising water and an alkali or alkaline earth metal phosphate and/or polyphosphate. The subject compositions are useful, inter alia, for providing elastomeric seals.
Patent AU-2462200-A (AU)
Title: Tablets quickly disintegrated in the oral cavity
Inventor: NISHII HIROYUKI
IPC: A61K9/00
Filed: 2000-02-14
Abstract: There is provided a tablet preparation showing quick disintegratability in the mouth and good sensory acceptability and yet having an adequate strength to resist damage in the course of distribution. Each tablet comprises a starch, a water-soluble excipient and a medicament and does not substantially contain a binder other than starch.
Patent AU-2497695-A (AU)
Title: Functional diene polymers, their method of preparation and their use in silica-filled elastomeric compositions which can be used for tires
Inventor: GORCE JEAN-NOEL
IPC: C08K3/36
Filed: 1995-07-13
Abstract: Diene polymers functionalised with an epoxidised alkoxysilane are prepd. by catalysed prepn. of a living diene polymer and addn. to the living polymer of an agent of formula (Y)m-R<1>-Si(OR<2>)3-n-R<3>n (I). In (I), Y = a gp. of formula (i) or (ii); R<1> = 1-10C alkyl, cycloalkyl or aryl; R<2> = 1-12C alkyl, aryl, cycloalkyl, alkaryl or aralkyl; R<3> = 1-12C alkyl, aryl or alkaryl; R<4> = 1-6C hydrocarbon gp., opt. with O atom(s) in the chain; n = 0 or 1; m = 1 or 2; p, q = 0-4; and p+q = 2-5. The amt. of (I) used is such that the molar ratio (RM) of (I):active sites in the initiator is at least 1. Redn. of the hysteresis of dienic polymer vulcanisates by modification with (I), and addn. of SiO2 and the usual components of S-vulcanisable compsns., is also claimed. <IMAGE>
Patent AU-2543199-A (AU)
Title: Methods for the preparation of nanosized material particles
Inventor: GARTI NISSIM
IPC: C09K23/00
Filed: 1999-02-16
Abstract: The present invention relates to a method for the production of particles of nano-materials being transition metals and alloys; metal oxides; and ceramic compositions having a small nanosize, i.e. about 1-6 nm. The method comprises a synthesis in the solutions of complex liquids from suitable precursors, which precursors are selected from suitable surfactants and alkoxides, by a suitable chemical reaction under mild conditions; and preparing from said materials fine colloids dispersed in various polymer solutions. The water in the solution is preferably non freezing water, the mild conditions are atmospheric pressure and a temperature range of room temperature to 70° C., and the reaction condition is selected among a hydrolysis, reduction and exchange process.
Patent AU-2652095-A (AU)
Title: Foldable rake implement
Inventor: DARNELL CLETE
IPC: A01D7/10
Filed: 1995-05-25
Abstract: A foldable rake implement includes an elongated handle having a proximal end to be grasped by the user and a distal end. An articulated frame structure is attached to the handle at the distal end. The articulated frame structure includes a central axis of articulation dividing the frame structure into two mirror-image first and second frame halves. The axis of articulation is coaxial with the handle and defines an axis about which the articulated frame structure moves between an unfolded position whereat the first and second frame halves of the frame structure symmetrically project outwardly to opposite lateral sides of the handle and a folded position whereat the first and second frame halves are moved toward each other and into generally mutual overlaying relationship. The articulated frame structure further includes a plurality of spaced-apart tines, a plurality of first tranverse fingers projecting outwardly from one side of the first frame half, and a plurality of second transverse fingers projecting outwardly from one side of the second frame half opposite the first fingers.
Patent AU-2703400-A (AU)
Title: Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application
Inventor: KHAVINSON VLADIMIR KHATSKELEVI
IPC: A61P39/06
Filed: 2000-01-20
Abstract: Tetrapeptide L-alanyl-L-glutamyl-L-aspartyl-glycine (SEQ ID NO: 1) of the general formula L-Ala-L-Glu-L-Asp-Gly (SEQ ID NO: 1) is proposed as a biologically active compound with a geroprotective effect. The use of L-Ala-L-Glu-L-Asp-Gly (SEQ ID NO: 1) tetrapeptide in medicine is proposed for preparing a substance displaying a geroprotective effect. There is proposed a pharmacological substance, which contains as its active base an effective amount of tetrapeptide of the formula L-alanyl-L-glutamyl-L-aspartyl-glycine (L-Ala-L-Glu-L-Asp-Gly) (SEQ ID NO: 1) or its salts of the amino group (acetate, hydrochloride, oxalate) and of carboxyl groups (the salts of metals-Sodium, Potassium, Calcium, Lithium, Zinc, Magnesium, and also the salts of organic and inorganic cations-ammonium and triethylammonium). The substance is proposed for parenteral, intranasal, oral administration, and local application. With respect to the invention, the method of premature ageing prevention involves prophylactic and/or therapeutic administration to a patient of the pharmacological substance in doses of 0.01 to 100 mug/kg of the body weight at least once a day for a period necessary for the achievement of a therapeutic effect.
Patent AU-2843799-A (AU)
Title: Improved temporary surface covering
Inventor: DESCHAMPS GEORGES-PAUL
IPC: D03D11/02
Filed: 1999-03-19
Abstract: A temporary surface covering with a woven structure formed of warp threads and weft threads and whose weave is such that each warp thread intersects or intertwines with the following weft threads, and a second auxiliary woven structure being superposed having a layer of warp threads and a layer of weft threads, the connection between the two woven structures being carried out in the course of a same weaving operation simultaneously with the overlapping of the structures, so as to constitute between the two structures, from place to place, tubular pockets oriented in the direction of the warp threads or in the direction of the weft threads, the pockets serving for the reception of elements devoted to various uses.
Patent AU-2883689-A (AU)
Title: The use of moclobemide to treat or prevent cognitive disorders
Inventor: AMREIN ROMAN
IPC: A61P25/28
Filed: 1989-01-27
Abstract: The use of p-chloro-N-(2-morpholinoethyl)benzamide (I) for treating and preventing cognitive disorders to new.
Patent AU-2889997-A (AU)
Title: An improved bottom profile for a can
Inventor: TAMIS PAULUS JOZEF
IPC: B65D1/16
Filed: 1997-04-29
Abstract: A thin metal pressure-resistant can comprising a can body having a deep-drawn and wall-ironed cylindrical side wall, the can body comprising an outwardly convexed bottom integrally with said body and an inwardly projecting dome.
Patent AU-2994401-A (AU)
Title: Passively mode-locked optically pumped semiconductor external-cavity surface-emitting laser
Inventor: PASCHOTTA RUDIGER
IPC: H01S5/06
Filed: 2001-02-09
Abstract: A passively mode-locked optically pumped semiconductor vertical-external-cavity surface-emitting laser (OPS-EXSEL) is disclosed. The laser is mode locked by a semiconductor saturable absorber mirror (SESAM) which forms part of an external cavity. Both the beam-quality limitations of edge-emitting lasers, and the power restrictions of electrically pumped surface-emitting lasers are overcome. The laser uses a semiconductor wafer in which a stack of quantum wells is grown adjacent to a single Bragg-mirror structure. Light from one or more multi-mode high-power diode lasers is focused onto the face of the wafer and pumps the wells by absorption in the barrier regions. The area of the laser mode on the active mirror can be about 10<4 >times larger than the mode area on the facet of an edge-emitting laser, offering scope for the generation of high average power and large pulse energy. At the same time the external cavity enforces fundamental mode operation in a circular, near-diffraction-limited beam. With the laser, sub-picosecond pulse durations are achievable by eliminating coupled cavity effects and by external pulse compression. Band-gap engineering can be used to shape the pulses, or even integrate gain and saturable absorption within the same wafer. Thus, rugged, efficient pulsed laser sources with high average power in a nearly diffraction-limited beam, sub-picosecond pulse durations and multi-GHz repetition rates, which operate in a broad range of wavelengths accessible by bandgap engineering are made possible.